Klaviyo: Overblown Fears, Buy Into The Panic Selling

Klaviyo remains rated a Buy despite a 30% post-Q1 selloff and shares near multi-year lows. Q1 was a beat and raise, with FY26 revenue guidance lifted to $1.51–$1.52 billion, implying 23% growth, though conservative Q2 guidance points to management caution rather than fundamental weakness. The note argues decelerating growth and AI-related concerns are not enough to justify the decline.

Analysis

Klaviyo remains rated a Buy despite a 30% post-Q1 selloff and shares near multi-year lows. Q1 was a beat and raise, with FY26 revenue guidance lifted to $1.51–$1.52 billion, implying 23% growth, though conservative Q2 guidance points to management caution rather than fundamental weakness. The note argues decelerating growth and AI-related concerns are not enough to justify the decline.